Table 1 Clinical characteristics of critically ill patient groups with severe ARDS
N | Mean/percent of patients | Quartiles | ||
|---|---|---|---|---|
1 | 3 | |||
Age | 55.74 | 48.50 | 64.25 | |
BMI | 29.74 | 25.10 | 32.65 | |
Female gender | 16 | 29.63% | ||
Survival | 55.56% | |||
Hospitalization (days) | 80.24 | 39.50 | 103.25 | |
ICU (days) | 65.17 | 33.00 | 83.25 | |
Ventilation days | 55.98 | 31.25 | 69.00 | |
Intubation in domo | 21 | 38.89% | ||
sPEEP (cmH2O) | 16.46 | 13.75 | 18.00 | |
pPeak (cmH2O) | 32.00 | 29.75 | 34.00 | |
RMV (l/min) | 8.39 | 7.30 | 9.60 | |
RR | 20.20 | 16.75 | 23.25 | |
PaO2/FiO2 | 73.44 | 65.75 | 77.75 | |
Intubation ex domo | 21 | 38.89% | ||
sPEEP (cmH2O) | 16.76 | 14.00 | 19.00 | |
pPeak (cmH2O) | 31.52 | 29.00 | 34.00 | |
RMV (l/min) | 8.12 | 6.60 | 9.80 | |
RR | 19.33 | 18.00 | 20.00 | |
ECMO ex domo | 12 | 22.22% | ||
sPEEP (cmH2O) | 12.67 | 12.00 | 15.00 | |
pPeak (cmH2O) | 24.67 | 22.75 | 27.50 | |
RMV (l/min) | 3.51 | 2.53 | 4.45 | |
RR | 15.00 | 12.75 | 16.00 | |
ECMO type | ||||
All | 37 | 68.5% | ||
VV | 34 | 63.0% | ||
VA | 3 | 5.6% | ||
Therapy | ||||
Tracheostomy | 43 | 79.6% | ||
Prone position | 50 | 92.6% | ||
NO | 28 | 51.9% | ||
Dexamethasone | 42 | 77.36% | ||
Tocilizumab | 11 | 20.37% | ||
NMBA | 31 | 57.41% | ||
Dialyse | 44 | 81.48% | ||
Nutrition | ||||
kcal/day | 1815.09 | 1431.11 | 2150.40 | |
Protein/day (g) | 112.43 | 86.40 | 126.72 | |